Skip to main content

Advertisement

SpringerLink
Log in

Immunogenicity of biologic agents: A new concern for the practicing rheumatologist?

  • Invited Commentary
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Baert F, Noman M, Vermeire S, et al.: Influence of immunogenicity on the long term efficacy of infliximab in Crohn’s disease. N Engl J Med 2003, 348:601–608.

    Article  PubMed  CAS  Google Scholar 

  2. Haraoui B, Cameron L, Ouellet M, et al.: Anti-infliximab antibodies in patients with rheumatoid arthritis who require higher doses of infliximab to achieve or maintain a clinical response. J Rheumatol 2006, 33:31–36.

    PubMed  CAS  Google Scholar 

  3. Weiner LM: Fully human therapeutic monoclonal antibodies. J Immunother 2006, 29:1–9.

    Article  PubMed  CAS  Google Scholar 

  4. Abbott Laboratories: Humira® (adalimumab) prescribing information. Available at http://www.rxabbort.com/pdf/humira.pdf. Accessed on May 14, 2007.

  5. Cohen SB, Greenwald M, Dougados M, et al.: Efficacy and safety of Rituximab in active RA patients who experienced an inadequate response to one or more anti-TNF alpha therapies (REFLEX Study) [abstract]. Arthritis Rheum 2005, 52:S677.

    Google Scholar 

  6. Klareskog L, Wajdula J, Baker P, et al.: Low and transient auto and anti-etanercept antibody formation has no measurable impact on clinical outcomes during 5 years of etanercept treatment in patients with rheumatoid arthritis [abstract]. Ann Rheum Dis 2006, 65:325.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Montreal Hospital Centre (CHUM), Notre-Dame Hospital, Department of Medicine, University of Montreal, Montreal, Quebec, Canada

    Boulos Haraoui MD

Authors
  1. Boulos Haraoui MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jean-Pierre Pelletier MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Johanne Martel-Pelletier PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Boulos Haraoui MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haraoui, B., Pelletier, JP. & Martel-Pelletier, J. Immunogenicity of biologic agents: A new concern for the practicing rheumatologist?. Curr Rheumatol Rep 9, 265–267 (2007). https://doi.org/10.1007/s11926-007-0042-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-007-0042-x

Keywords

Search

Navigation